Lmr Partners LLP Guardant Health, Inc. Transaction History

Lmr Partners LLP

$10.9 Billion
Q3 2024

A detailed history of Lmr Partners LLP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 10,000 shares of GH stock, worth $315,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,000

Holding current value

$315,700

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$22.3 - $36.29 $223,000 - $362,900	10,000 New	10,000 $229,000
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $5.35 Million - $7.48 Million	-122,633 Reduced 76.34%	38,011 $2.05 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $3.97 Million - $10.7 Million	137,702 Added 600.22%	160,644 $6.48 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $6.01 Million - $12.5 Million	-124,605 Reduced 84.45%	22,942 $1.52 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $8.77 Million - $11.9 Million	98,826 Added 202.84%	147,547 $14.8 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $4.81 Million - $6.44 Million	48,721 New	48,721 $6.09 Million
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $3.86 Million - $5.82 Million	-35,153 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $4.47 Million - $6.3 Million	35,153 New	35,153 $5.37 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$369 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$355 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$320 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$219 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$189 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account